Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com
Analysts at StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Performance Evoke Pharma stock opened at $4.82 on Monday. Evoke Pharma has a fifty-two […]
Analysts at StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Performance Evoke Pharma stock opened at $4.82 on Monday. Evoke Pharma has a fifty-two […]
